Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Colorado, CO
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Colorado, CO
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Connecticut, CT
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Connecticut, CT
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Delaware, DE
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Delaware, DE
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Florida, FL
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Florida, FL
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Georgia, GA
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Georgia, GA
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Illinois, IL
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Illinois, IL
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Indiana, IN
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Indiana, IN
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Kansas, KA
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Kansas, KA
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Kentucky, KY
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Kentucky, KY
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Louisiana, LA
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Louisiana, LA
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Maine, ME
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Maine, ME
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Maryland, MD
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Maryland, MD
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Massachusetts, MA
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Massachusetts, MA
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Michigan, MI
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Michigan, MI
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Minnesota, MN
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Minnesota, MN
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Missouri, MO
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Missouri, MO
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Montana, MT
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Montana, MT
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Nebraska, NE
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Nebraska, NE
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Nevada, NV
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Nevada, NV
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in New Jersey, NJ
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in New Jersey, NJ
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in New York, NY
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in New York, NY
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in North Carolina, NC
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in North Carolina, NC
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Ohio, OH
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Ohio, OH
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Oklahoma, OK
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Oklahoma, OK
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Oregon, OR
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Oregon, OR
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Pennsylvania, PA
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Pennsylvania, PA
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Rhode Island, RI
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Rhode Island, RI
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in South Carolina, SC
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in South Carolina, SC
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Tennessee, TN
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Tennessee, TN
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Texas, TX
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Texas, TX
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Utah, UT
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Utah, UT
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Vermont, VT
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Vermont, VT
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Virginia, VA
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Virginia, VA
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Washington, WA
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Washington, WA
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in West Virginia, WV
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in West Virginia, WV
Click here to add this to my saved trials
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Russia,
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
The FLASH Study: A Randomized, Controlled Study of Roflumilast 250 mcg and 500 mcg Versus Placebo in Patients With Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Russia,
Click here to add this to my saved trials
Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)
A 24-Week, Double-Blind, Parallel Group, Placebo and Active Controlled Study to Investigate the Efficacy and Safety of Daily Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Chronic Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Georgia, GA
Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)
A 24-Week, Double-Blind, Parallel Group, Placebo and Active Controlled Study to Investigate the Efficacy and Safety of Daily Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Chronic Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Georgia, GA
Click here to add this to my saved trials
Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)
A 24-Week, Double-Blind, Parallel Group, Placebo and Active Controlled Study to Investigate the Efficacy and Safety of Daily Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Chronic Asthma
Status: Enrolling
Updated:  12/1/2016
ALTANA Pharma
mi
from
Cities in Austria,
Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)
A 24-Week, Double-Blind, Parallel Group, Placebo and Active Controlled Study to Investigate the Efficacy and Safety of Daily Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Chronic Asthma
Status: Enrolling
Updated: 12/1/2016
ALTANA Pharma
mi
from
Cities in Austria,
Click here to add this to my saved trials
Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma
Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma
Status: Enrolling
Updated:  12/6/2016
Norton Children's Hospital
mi
from
Louisville, KY
Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma
Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma
Status: Enrolling
Updated: 12/6/2016
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Little Rock, AR
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Alhambra, CA
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Alhambra, CA
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Costa Mesa, CA
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Huntington Beach, CA
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Newport Beach, CA
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Homestead, FL
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Homestead, FL
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Miami, FL
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Miami, FL
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Miami, FL
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Raleigh, NC
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  12/12/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of Once-daily Inhaled Fluticasone Furoate Inhalation Powder for Six Weeks on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 12/12/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials